Skip to content

Company
Pipeline
For Investors
Contact

Company
Pipeline
For Investors
Contact

Press Releases

Choose Year
Search Press Releases

Found 269 Results

October 16, 2014

Relmada Therapeutics Reinforces Balance Sheet With $15.2 Million From Exercise Of Warrants

October 9, 2014

New Report Initiates Coverage on New Public Biopharmaceutical Company, Relmada Therapeutics, Inc.

October 2, 2014

Relmada Therapeutics Appoints Julie J. Chen As Director of Finance and Operations

September 18, 2014

Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development

September 16, 2014

Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER

September 10, 2014

Relmada Announces The Filing Of Clinical Trial Application In Canada For d-methadone

September 9, 2014

Relmada Therapeutics, Inc. Provides Its First Corporate Update as a Public Company

September 3, 2014

Relmada Therapeutics to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th, 2014

August 6, 2014

Relmada Therapeutics, Inc. Completes Name Change and Announces New Ticker

«...22 23 24 25 2627

IR Contact

Brian Ritchie
LifeSci Advisors, LLC

+1 (212) 915-2578
britchie@lifesciadvisors.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy^*

Unsubscribe

Loading...

Company

Pipeline
Overview
NDV-01
Speranolone

For Investors
Summary
News
Events
SEC Filings
Corporate Governance
Stock Information

Contact

info@relmada.com

+1 (786) 629-1376

©2026 Relmada Therapeutics, Inc.

Privacy Policy
Terms of Use

Scroll to Top